Clinical Study
Reduced ErbB4 Expression in Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis
Table 1
Study Participants.
| Participants | Blood donors () | Age (yrs) | Female: male |
| All RR MS patients | 18 | 34.7 ± 14.2 | 12 : 6 | Untreated patients | 7 | 32.1 ± 8.5 | 5 : 2 | Interferon--treated patients | 11 | 36.2 ± 9.9 | 7 : 4 | Healthy controls | 15 | 35.6 ± 6.8 | 10 : 5 |
|
|